198 related articles for article (PubMed ID: 25030865)
1. [Recurrent Müllerian adenofibroma of uterus: a clinicopathologic study of 7 cases].
Shi H; Chen X; Zhang X; Zhou C; Yu M
Zhonghua Bing Li Xue Za Zhi; 2014 May; 43(5):321-5. PubMed ID: 25030865
[TBL] [Abstract][Full Text] [Related]
2. Mullerian adenosarcoma: a clinicopathologic and immunohistochemical study of 55 cases challenging the existence of adenofibroma.
Gallardo A; Prat J
Am J Surg Pathol; 2009 Feb; 33(2):278-88. PubMed ID: 18941402
[TBL] [Abstract][Full Text] [Related]
3. Mullerian adenosarcomas: an immunophenotypic analysis of 35 cases.
Soslow RA; Ali A; Oliva E
Am J Surg Pathol; 2008 Jul; 32(7):1013-21. PubMed ID: 18469708
[TBL] [Abstract][Full Text] [Related]
4. Mullerian adenosarcoma of the female genital tract.
McCluggage WG
Adv Anat Pathol; 2010 Mar; 17(2):122-9. PubMed ID: 20179434
[TBL] [Abstract][Full Text] [Related]
5. [Clinicopathologic analysis of 102 cases of mixed epithelial and mesenchymal tumors of the uterus].
Chen XD; Shi HY; Zhang XF
Zhonghua Fu Chan Ke Za Zhi; 2007 Apr; 42(4):219-21. PubMed ID: 17631758
[TBL] [Abstract][Full Text] [Related]
6. Uterine adenosarcomas: diagnostic use of the proliferation marker Ki-67 as an adjunct to morphologic diagnosis.
Aggarwal N; Bhargava R; Elishaev E
Int J Gynecol Pathol; 2012 Sep; 31(5):447-52. PubMed ID: 22833085
[TBL] [Abstract][Full Text] [Related]
7. Adenofibroma and adenosarcoma of the uterus: a clinicopathologic study of 35 cases.
Zaloudek CJ; Norris HJ
Cancer; 1981 Jul; 48(2):354-66. PubMed ID: 6263458
[TBL] [Abstract][Full Text] [Related]
8. [Prognosis-related clinicopathologic characteristics of FIGO stage Ⅰ Müllerian adenosarcoma of uterus].
Wang Y; Liu AJ; Chen X; Song X
Zhonghua Bing Li Xue Za Zhi; 2018 May; 47(5):334-338. PubMed ID: 29783798
[No Abstract] [Full Text] [Related]
9. [Clinicopathologic characteristics of Müllerian adenosarcoma of uterus:a comparative analysis of 7 cases before and after surgery].
Yu J; Zhu HT
Zhonghua Bing Li Xue Za Zhi; 2013 Aug; 42(8):547-8. PubMed ID: 24246922
[No Abstract] [Full Text] [Related]
10. Immunohistochemical expression of CD10 antigen in uterine adenosarcoma.
Amant F; Steenkiste E; Schurmans K; Verbist L; Abeler VM; Tulunay G; de Jonge E; Massuger L; Moerman P; Vergote I
Int J Gynecol Cancer; 2004; 14(6):1118-21. PubMed ID: 15571618
[TBL] [Abstract][Full Text] [Related]
11. Expression of CD10 in malignant müllerian mixed tumors and adenosarcomas: an immunohistochemical study.
Mikami Y; Hata S; Kiyokawa T; Manabe T
Mod Pathol; 2002 Sep; 15(9):923-30. PubMed ID: 12218209
[TBL] [Abstract][Full Text] [Related]
12. Immunohistochemical markers and the clinical course of adenosarcoma: a series of seven cases.
Omi M; Tonooka A; Chiba T; Tanaka Y; Fusegi A; Aoki Y; Nomura H; Kanao H; Takazawa Y
Diagn Pathol; 2020 Sep; 15(1):119. PubMed ID: 32972432
[TBL] [Abstract][Full Text] [Related]
13. [Adenofibroma and adenosarcoma of the uterus in young women].
Sölder E; Huter O; Müller-Holzner E; Brezinka C
Geburtshilfe Frauenheilkd; 1995 Feb; 55(2):118-20. PubMed ID: 7758894
[TBL] [Abstract][Full Text] [Related]
14. Uterine Adenosarcoma.
Pinto A; Howitt B
Arch Pathol Lab Med; 2016 Mar; 140(3):286-90. PubMed ID: 26927725
[TBL] [Abstract][Full Text] [Related]
15. Uterine smooth muscle tumors of uncertain malignant potential (STUMP): a clinicopathologic analysis of 16 cases.
Ip PP; Cheung AN; Clement PB
Am J Surg Pathol; 2009 Jul; 33(7):992-1005. PubMed ID: 19417585
[TBL] [Abstract][Full Text] [Related]
16. [A light and electron microscopic studies of müllerian adenofibroma of the uterus].
Iwai M; Konishi I; Fujii S; Kawaguchi K; Okamura H; Suzuki A
Nihon Sanka Fujinka Gakkai Zasshi; 1984 Jan; 36(1):44-8. PubMed ID: 6321614
[TBL] [Abstract][Full Text] [Related]
17. [Mullerian adenosarcoma of the uterus: A clinicopathologic analysis of 9 cases].
Han XY; Xiang Y; Guo LN; Sheng K; Wan XR; Huang HF; Pan LY
Zhonghua Zhong Liu Za Zhi; 2010 Jan; 32(1):44-7. PubMed ID: 20211067
[TBL] [Abstract][Full Text] [Related]
18. High-grade Müllerian Adenosarcoma: Genomic and Clinicopathologic Characterization of a Distinct Neoplasm With Prevalent TP53 Pathway Alterations and Aggressive Behavior.
Hodgson A; Amemiya Y; Seth A; Djordjevic B; Parra-Herran C
Am J Surg Pathol; 2017 Nov; 41(11):1513-1522. PubMed ID: 28834809
[TBL] [Abstract][Full Text] [Related]
19. The diagnosis and treatment of Mullerian adenosarcoma of the uterus.
Shi Y; Liu Z; Peng Z; Liu H; Yang K; Yao X
Aust N Z J Obstet Gynaecol; 2008 Dec; 48(6):596-600. PubMed ID: 19133051
[TBL] [Abstract][Full Text] [Related]
20. Müllerian Adenosarcoma of the Urinary Bladder: Clinicopathologic and Immunohistochemical Features With Novel Genetic Aberrations.
Sanfrancesco J; Williamson SR; Kum JB; Zhang S; Wang M; Lopez-Beltran A; Montironi R; Gardner TA; Cheng L
Clin Genitourin Cancer; 2017 Dec; 15(6):e1007-e1014. PubMed ID: 28690098
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
